Christopher Kim

APUS

Christopher Kim serves as Chairman and CMO at Apimeds Pharmaceuticals US, Inc (APUS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$50.4K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$50.4K

Companies Traded

APUS

Active Period

May 2025

1 total trades

Most Recent

Buy APUS

May 13, 2025 · $50.4K

Christopher Kim's Insider Trading at Apimeds Pharmaceuticals US, Inc (APUS)

Buys

1 · $50.4K

Sells

0 · $0.00

Total Shares Bought

27,500

Total Shares Sold

APUS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 13, 2025	Buy	27,500	$1.83	$50.4K	0

Explore More Insider Trading Data

APUS Insider Trading Activity

View all insider trades at Apimeds Pharmaceuticals US, Inc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity